Stay updated with breaking news from Executive Tim Mccarthy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Immupharma PLC on Tuesday announced a new intellectual property strategy to significantly enhance the patent life and commercial value for its P140 technology platform. Shares in Immupharma, the...
By Kyle Morris Shares in ImmuPharma PLC rose 9.4% on Monday after the company said it has submitted a Phase 2/3 clinical trial protocol to the U.S. Food and Drug Administration for its Lupuzor... | March 27, 2023
IN BRIEF: Immupharma gets US FDA approval for Lupuzor pre-trial study | Financial News